Human prostate carcinoma cell lines secrete GM-CSF and express GM-CSF-receptor on their cell surface

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 557-564

  Rokhlin, Oskar W ^a   Griebling, Tomas L ^a   Karassina, Natalia V ^a   Raines, Maribeth A ^b   Cohen, Michael B ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytokine; ELISA; Flow cytometry; Prostatic neoplasms

Indexed keywords

CADHERIN; CELL SURFACE RECEPTOR; ENDOGLIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN;

ARTICLE; CELL PROLIFERATION; CELL SURFACE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; TUMOR CELL LINE;

CELL ADHESION MOLECULES; CELL DIVISION; CYTOKINES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MALE; MEMBRANE PROTEINS; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; TUMOR CELLS, CULTURED;

EID: 0029973703     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wingo PA, Tong T and Bolden S: Cancer statistics CA Cancer J Clin 45: 8-30, 1995
2. Jacobs SC, Pinka D and Lawson RK: Prostatic osteoblast factor. Invest Urol 17: 195-198, 1979.
3. Perkel VS, Mohan S, Herring SJ, Baylink DJ and Linkhart TA: Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells. Cancer Res 50: 6902-6907, 1990.
4. Rabbani SA, Desjardins J, Bell AW, Banville D, Mazar A, Henkin J and Goltzman D: An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells. BBRC 173: 1058-1064, 1990.
5. Killian CS, Corral DA, Kawinski E and Constantine RI: Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-β and a proteolytic modulation of cell adhesion receptors. BBRC 192: 940-947, 1993.
6. Koutsilieris M: Osteoblastic metastasis in advanced prostate cancer. Anticancer Res 13: 443-450, 1993.
7. Avanzi GC, Brizzi MF, Giannotti J, Ciarletta A, Yang Y-C, Pegoraro L and Clark SC: M-O7e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3. J Cell Physiol 145: 458-464, 1990.
8. Narayan P and Dahiya R: Establishment and characterization of a human primary prostate adenocarcinoma cell line (ND-1). J Urol 148: 1000-1004, 1992.
9. Loop SM, Rozanski TA and Ostenson RC: Human primary prostate tumor cell line, ALVA-31: A new model for studying the hormonal regulation of prostate tumor cell growth. Prostate 22: 93-108, 1993.
10. Rokhlin OW, Cohen MB, Kubagawa H, Letarte M and Cooper MD: Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow. J Immunol 154: 4456-4465, 1995.
11. Hendric P, Miyazawa K, Yang Y-C, Langefeld CD and Broxmeyer HE: Mast cell growth factor (c-kit ligand) enhances cytokine stimulation on proliferation of the human factor-dependent cell line, MO7e. Exp Hematol 19: 1031-1037, 1991.
12. Rokhlin OW and Cohen MB: Expression of cellular adhesion molecules on human prostate tumor cell line. Prostate 26: 205-212, 1995.
13. Stevens JW, Palechek PL, Midura RJ, Rokhlin OW and Cohen MB: Expression of CD44 isoforms in human prostate tumor cell lines. Prostate (in press)
14. Ruff MR, Farrar WL and Pert CB: Interferon g and granulocyte/macrophage colony-stimulating factor inhibit growth and induce antigens characteristic of myeloid differentiation in small-cell lung cancer cell lines. Proc Natl Acad Sci USA 83: 6613-6617, 1986.
15. Baldwin GC, Gasson JC, Kaufman SE, Quan SG, Williams RE, Avalos BR, Gazdar AF, Golde DW and DiPersio JF: Nonhematopoietic tumor cells express functional GM-CSF receptors. Blood 73: 1033-1037, 1989.
16. Dedhar S, Gaboury L, Galloway P and Eaves C: Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin. Proc Natl Acad Sci USA 85: 9253-9257, 1988.
17. Berdel WE, Danhauser-Riedl S, Steinhauser G and Winton EF: Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 73: 80-83, 1989.
18. Gasson JC: Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77: 1131-1145, 1991.
19. Zinzar SN, Svet-Moldavsky GJ, Fogh J, Mann PE, Arlin Z, Iliescu K and Holland JF: Elaboration of granulocyte-macrophage colony-stimulating factor by human tumor cell lines and normal urothelium. Exp Hematol 13: 574-580, 1985.
20. Lang SH, Miller WR, Duncan W and Habib FK: Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor. Int J Cancer 59: 235-241, 1944.
21. Kaighn ME, Narayan KS, Ohnaki Y, Lechner JF and Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23, 1974.
22. Miyajima A, Mui A L-F, Ogorochi T and Sakamaki K: Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82: 1960-1974, 1993.
23. Polotskaya A, Zhao Y, Lilly ML and Kraft AS: A critical role for the cytoplasmic domain of the granulocyte-macrophage colony-stimulating factor a receptor in mediating cell growth. Cell Growth Differ 4: 523-531, 1993.
24. Polotskaya A, Zhao Y, Lilly MB and Kraft AS: Mapping the intracytoplasmic regions of the a granulocyte-macrophage colony-stimulating factor receptor necessary for cell growth regulation. J Biol Chem 269: 14607-14613, 1994.
25. Ding D X-H, Rivas CI, Heaney ML, Raines MA, Vera JC and Golde DW: The a subunit of the human granulocyte-macrophage colony-stimulating factor receptor signals for glucose transport via a phosphorylation-independent pathway. Proc Natl Acad Sci USA 91: 2537-2541, 1994.
26. Dranoff G, Jaffce E, Lazenby A, Golumbek P, Levitsky F, Brose K, Jackson V, Hamada H, Pardoll DM and Mulligan RC: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci 90: 3539-3543, 1993.
27. Vieweg J, Rosenthal FM, Bannerji R, Heston WDW, Fair WR, Gansbacher B and Gilboa E: Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines. Cancer Res 54: 1760-1765, 1994.
28. Sanda MG, Ayyagari SR, Jaffee EM, Epstein J, Clift SL, Cohen LK, Dranoff G, Pardoll DW, Mulligan RC and Simons JW: Demonstration of a rational strategy for human prostate cancer gene therapy. J Urol 151: 622-628, 1994.